Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around

Description

Summary

Official Title

PREVENT ALL ALS - Longitudinal Biomarker Study for Participants Who Are Genetically at Risk for Amyotrophic Lateral Sclerosis (ALS)

Keywords

Amyotrophic Lateral Sclerosis, ALS, Biomarker, Observational, at-risk, Motor Neuron Disease, Sclerosis

Eligibility

Locations

  • UCSF accepting new patients
    San Francisco California 94143 United States
  • University of California Irvine accepting new patients
    Orange California 92868 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
St. Joseph's Hospital and Medical Center, Phoenix
ID
NCT06581861
Study Type
Observational
Participants
Expecting 600 study participants
Last Updated